Our top pick for
Generation Bio Co is a biotechnology business based in the US. Generation Bio shares (GBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Generation Bio employs 100 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$22.45|
|52-week range||$19.16 - $55.72|
|50-day moving average||$25.09|
|200-day moving average||$26.83|
|Wall St. target price||$39.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.99|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||0.13%|
|1 month (2021-09-15)||-15.60%|
|3 months (2021-07-15)||12.25%|
|6 months (2021-04-15)||-18.42%|
|1 year (2020-10-15)||-13.65%|
|2 years (2019-10-11)||N/A|
|3 years (2018-10-11)||N/A|
|5 years (2016-10-11)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-15.48%|
|Return on equity TTM||-27.5%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
There are currently 6.4 million Generation Bio shares held short by investors – that's known as Generation Bio's "short interest". This figure is 6.3% down from 6.8 million last month.
There are a few different ways that this level of interest in shorting Generation Bio shares can be evaluated.
Generation Bio's "short interest ratio" (SIR) is the quantity of Generation Bio shares currently shorted divided by the average quantity of Generation Bio shares traded daily (recently around 284569.74153298). Generation Bio's SIR currently stands at 22.44. In other words for every 100,000 Generation Bio shares traded daily on the market, roughly 22440 shares are currently held short.
However Generation Bio's short interest can also be evaluated against the total number of Generation Bio shares, or, against the total number of tradable Generation Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Generation Bio's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Generation Bio shares in existence, roughly 110 shares are currently held short) or 0.1538% of the tradable shares (for every 100,000 tradable Generation Bio shares, roughly 154 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Generation Bio.
Find out more about how you can short Generation Bio stock.
We're not expecting Generation Bio to pay a dividend over the next 12 months.
Generation Bio Co. , a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.